TrialAlzheimer's research & therapy2016

First-In-Human safety and long-term exposure data for AAB-003 (PF-05236812) and biomarkers after intravenous infusions of escalating doses in patients with mild to moderate Alzheimer's disease.

Marielle Delnomdedieu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.